PIK3CA and neoplasm: Conversely, one case harbored a low level subclonal PIK3CA mutation that was discovered by a clinical genomics panel in the primary tumor, but was not identified by WES in different primary tumor blocks from the same case, nor in multiple samplings of the recurrent tumor.